Nova Patents
AT239496T

Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production

Abstract

The present invention relates to a FUNCTIONALITY a variant of human interleukin (HIL-3) or mutant proteins (muteins) coadministered with other factors STIMULUS COLOGNE (CSF), cytokines, lymphokines, interleukins, growth factors Hematopoietic OR VARIATIONS IL-3.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

146 members in 22 offices

This recordMember, by publication datePriority claim12 more offices are in the list below

Priority claims8

Priority claims
DocumentOfficeKindDate
19337394United States of AmericaA
19337394United States of AmericaA
9501184United States of AmericaW
9501184United States of AmericaW
193373–––
9501184–––
US19940193373–––
WO1995US01184–––

Members146

Family members, oldest first
DocumentOfficeKind
CA2150116A1CanadaA1
CA2150117A1CanadaA1
WO9412638A2World Intellectual Property Organization (WIPO)A2
WO9412639A2World Intellectual Property Organization (WIPO)A2
AU5612594AAustraliaA
AU5670994AAustraliaA
WO9412639A3World Intellectual Property Organization (WIPO)A3
WO9412638A3World Intellectual Property Organization (WIPO)A3
CA2182473A1CanadaA1
CA2182474A1CanadaA1
CA2182483A1CanadaA1
CA2182484A1CanadaA1
WO9520976A1World Intellectual Property Organization (WIPO)A1
WO9520977A1World Intellectual Property Organization (WIPO)A1
WO9521197A1World Intellectual Property Organization (WIPO)A1
WO9521254A1World Intellectual Property Organization (WIPO)A1
AU1680595AAustraliaA
AU1695395AAustraliaA
AU1835695AAustraliaA
AU1909995AAustraliaA
EP0670898A1European Patent Office (EPO)A1
EP0672145A1European Patent Office (EPO)A1
KR950704490ARepublic of KoreaA
JPH08503489AJapanA
JPH08503706AJapanA
NO963225D0NorwayD0
FI963072AFinlandA
NO963225LNorwayL
EP0741576A1European Patent Office (EPO)A1
EP0742720A1European Patent Office (EPO)A1
EP0742796A1European Patent Office (EPO)A1
EP0742826A1European Patent Office (EPO)A1
PL315791A1PolandA1
CZ229896A3CzechiaA3
KR970700766ARepublic of KoreaA
US5604116AUnited States of AmericaA
MX9603205AMexicoA
JPH09508524AJapanA
JPH09508625AJapanA
BR9506733ABrazilA
US5677149AUnited States of AmericaA
JPH10502801AJapanA
US5738849AUnited States of AmericaA
AU690088B2AustraliaB2
NZ279624ANew ZealandA
NZ281421ANew ZealandA
AU6078398AAustraliaA
US5772992AUnited States of AmericaA
US5817486AUnited States of AmericaA
AU697433B2AustraliaB2
AU700220B2AustraliaB2
US5858347AUnited States of AmericaA
NZ329952ANew ZealandA
CN1227604AChinaA
HK1013655A1Hong Kong, ChinaA1
NZ330060ANew ZealandA
US5997857AUnited States of AmericaA
US5997860AUnited States of AmericaA
US6022535AUnited States of AmericaA
US6030812AUnited States of AmericaA
US6051217AUnited States of AmericaA
US6057133AUnited States of AmericaA
US6060047AUnited States of AmericaA
US6074639AUnited States of AmericaA
US6093395AUnited States of AmericaA
US6132991AUnited States of AmericaA
US6153183AUnited States of AmericaA
US6361976B1United States of AmericaB1
US6361977B1United States of AmericaB1
CA2182483CCanadaC
CZ289904B6CzechiaB6
EP1199080A2European Patent Office (EPO)A2
US6379662B1United States of AmericaB1
US6403076B1United States of AmericaB1
EP0741576B1European Patent Office (EPO)B1
AT218882TAustriaT
ATE218882T1AustriaT1
US6413509B1United States of AmericaB1
DE69527041D1GermanyD1
US6436387B1United States of AmericaB1
US6440407B1United States of AmericaB1
PT741576EPortugalE
US6458931B1United States of AmericaB1
DK0741576T3DenmarkT3
US6479261B1United States of AmericaB1
KR100332139B1Republic of KoreaB1
DE69527041T2GermanyT2
RO118016B1RomaniaB1
EP1283264A2European Patent Office (EPO)A2
ES2180624T3SpainT3
EP0742796B1European Patent Office (EPO)B1
EP0672145B1European Patent Office (EPO)B1
EP0742720B1European Patent Office (EPO)B1
KR100370264B1Republic of KoreaB1
AT237641TAustriaT
AT238421TAustriaT
AT239496TThis recordAustriaT
ATE237641T1AustriaT1
ATE238421T1AustriaT1
ATE239496T1AustriaT1
Showing 100 of 146